Assignee
ONCOLYS BIOPHARMA INC
JP·2 granted patents·7 pending applications·11 citations·filing 2000–2022
Top patents by PatentIndex Score
9 records- 0182US7943373B2Telomelysin/GFP-expressing recombinant virusONCOLYS BIOPHARMA INC·Filed 2005·Granted May 17, 2011·10 cites·3 claims
- 0254US2025026734A1Anti-sars-cov-2 drugONCOLYS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0352US7038028B1Gene encoding promoter domain of tumor suppressor gene P51 and use thereofONCOLYS BIOPHARMA INC·Filed 2000·Granted May 2, 2006·1 cites·3 claims
- 0452US2008032283A1Telomelysin/gfp-expressing recombinant virusONCOLYS BIOPHARMA INC·Filed 2007·Application pending·0 cites
- 0549US2022249127A1Method for administering oncolytic virus to tumor tissue, and device for administrationONCOLYS BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 0649US2023192622A1Anti-sars-cov-2 drugONCOLYS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0747US2009181931A1Antiviral activity of cidofovir against oncolytic virusesONCOLYS BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 0844US2011111480A1Telomelysin/GFP-expressing recombinant virusONCOLYS BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 0938US2010150884A1Anticancer Agent to Be Combined with TelomelysinONCOLYS BIOPHARMA INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCOLYS BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →